Patents by Inventor Marc Correvon

Marc Correvon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10105072
    Abstract: Measurement device for measuring a bio-impedance and/or a bio-potential of a human or animal body and adapted to be worn on the body, including: at least two electrode sensors. Each of the at least two electrode sensors includes a first electrical contact configured to be in electrical contact with the skin of the body when the system is worn, and a second electrical contact. A single electrical connector electrically connects the at least two electrode sensors with each other via the second electrical contact. An active device is configured to cooperate with a subset of the at least two electrode sensors such that the potential of the electrical connector is substantially equal to a projected potential determined from the potential of the first electrical contact of each electrode sensor of the subset when the measurement device is worn.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: October 23, 2018
    Assignee: CSEM CENTRE SUISSE D'ELECTRONIQUE ET DE MICROTECHNIQUE SA—RECHERCHE ET DÉVELOPPEMENT
    Inventors: Olivier Chetelat, Marc Correvon
  • Patent number: 9687162
    Abstract: The present disclosure relates to a method for estimating blood constituent concentration of a user under low perfusion conditions using a spectrophotometry-based monitoring device; the method comprising: measuring a plurality of photoplethysmographic (PPG) signals; measuring a cardio-synchronous (CV) signal; detecting an instantaneous heart rate and determining a heart rate variability from the CV signal; selecting reliable projected PPG signals; estimating a value of said blood constituent concentration from the magnitude of said reliable projected PPG signals. The disclosed method requires diminished computational load compared to conventional methods based on frequency domain approach as FFT or DCT. The disclosure also pertains to a monitoring device for estimating blood constituent concentration in tissue under low perfusion of a user.
    Type: Grant
    Filed: February 28, 2012
    Date of Patent: June 27, 2017
    Assignee: CSEM CENTRE SUISSE D'ELECTRONIQUE ET DE MICROTECHNIQUE SA—RECHERCHE ET DÉVELOPPEMENT
    Inventors: Rolf Vetter, Leopoldo Rossini, Andrea Ridolfi, Josep Sola i Caros, Marc Correvon
  • Publication number: 20150173677
    Abstract: Measurement device for measuring a bio-impedance and/or a bio-potential of a human or animal body and adapted to be worn on the body, including: at least two electrode sensors. Each of the at least two electrode sensors includes a first electrical contact configured to be in electrical contact with the skin of the body when the system is worn, and a second electrical contact. A single electrical connector electrically connects the at least two electrode sensors with each other via the second electrical contact. An active device is configured to cooperate with a subset of the at least two electrode sensors such that the potential of the electrical connector is substantially equal to a projected potential determined from the potential of the first electrical contact of each electrode sensor of the subset when the measurement device is worn.
    Type: Application
    Filed: December 19, 2014
    Publication date: June 25, 2015
    Inventors: Olivier Chetelat, Marc Correvon
  • Publication number: 20120190948
    Abstract: The present disclosure relates to a method for estimating blood constituent concentration of a user under low perfusion conditions using a spectrophotometry-based monitoring device; the method comprising: measuring a plurality of photoplethysmographic (PPG) signals; measuring a cardio-synchronous (CV) signal; detecting an instantaneous heart rate and determining a heart rate variability from the CV signal; selecting reliable projected PPG signals; estimating a value of said blood constituent concentration from the magnitude of said reliable projected PPG signals. The disclosed method requires diminished computational load compared to conventional methods based on frequency domain approach as FFT or DCT. The disclosure also pertains to a monitoring device for estimating blood constituent concentration in tissue under low perfusion of a user.
    Type: Application
    Filed: February 28, 2012
    Publication date: July 26, 2012
    Applicant: CSEM SA
    Inventors: Rolf Vetter, Leopoldo Rossini, Andrea Ridolfi, Josep Sola i Caros, Marc Correvon